6 results about "Autoregulation" patented technology

A muscle and bone dredging instrument disclosed by the present invention comprises a host and a pole piece, the host is provided with a display screen and a host power line, the host is provided with an adjusting key, a display lamp, a plurality of keys and a wire plugging hole, the pole piece is provided with an electrode socket, one end of the electrode socket is provided with a pole needle, and the other end of the electrode socket is provided with a wire. The invention relates to the technical field of physiotherapy equipment, and the core principle is that positioning electric energy is output through a body-controlled high-energy biological electro-therapeutic apparatus and is conducted to the body of a patient by a professionally trained electro-therapist through self-adjustment of current intensity, and sine wave current matched with human body cell bioelectricity waveform is utilized to excite essence and qi to dredge the channels and collaterals, so that the body-controlled high-energy biological electro-therapeutic apparatus can be used for treating body diseases. Therefore, the treatment effect that pain is not caused by general communication is achieved.

An example autoregulation monitoring system includes processing circuitry configured to receive a blood pressure signal indicative of a blood pressure of a patient; determine a derivative of at least a portion of the blood pressure signal; determine, based on the derivative, a characteristic arterial pressure (CAP) value; determine, based on the CAP value, an autoregulation value of the patient; and output a signal indicative of the autoregulation value of the patient.

The system includes a first sensor for continuously measuring a signal of renal blood flow of a patient. The second sensor continuously measures an arterial pressure signal of the patient. A blood flow monitor is in communication with the first and second sensors. The blood flow monitor includes a processor and a system memory storing monitoring software code. The processor is configured to execute the monitoring software code to assess a flow rate of the renal blood flow of the patient from the renal blood flow signal and to monitor a change in the flow rate of the renal blood flow over time. The processor is further configured to execute the monitoring software code to monitor changes in the arterial pressure signal over time and evaluate a mathematical relationship between the changes in the arterial pressure signal and changes in the flow rate of the renal blood flow.

The present invention relates to a therapeutic agent comprising an autoregulation element, preferably wherein the therapeutic agent is an antigen binding protein. Methods of treatment comprising use of said agent are also disclosed.